My mission is to advance precision medicine discovery and implementation across the healthcare and research sectors. I have extensive expertise in pharmacoepidemiology, pharmacogenomics, drug safety assessment, and genetic biomarker testing. I have published high-impact papers on real-world evidence combining electronic health records, genetics, and imaging data to identify biomarkers and risk factors for various diseases, such as long COVID, osteoarthritis, psychiatric disorders, and rare diseases. I have also led and collaborated with multiple national and international clinical consortia and industry partners to facilitate data sharing and integration, and to accelerate translational research.